Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm Files $100M Shelf Registration

NEW YORK (GenomeWeb News) – Fluidigm today filed a shelf registration to offer from time to time up to $100 million in securities.

In its Form S-3 filed with the US Securities and Exchange Commission, the South San Francisco, Calif.-based firm said that proceeds would go toward working capital and other general corporate purposes. A portion may also be used to acquire and invest in complementary products, technologies, or businesses, though Fluidigm added that it currently is not involved in any commitments or negotiations for such transactions.

Fluidigm President and CEO Gajus Worthington said at an investment conference in January that the firm is "quite interested" in acquisitions that would complement its portfolio.

In the SEC filing today, it said that securities that may be offered include any combinations of common stock, preferred stock, debt securities, and warrants.

Fluidigm went public in February 2011, netting $78 million in proceeds. The company recently reported a 26 percent hike year over year in revenues for the fourth quarter.

Filed under

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.